Tepotinib in non-small cell lung cancer (NSCLC) with MET-exon 14 skipping mutations (METex14+) and MET amplification (METamp): A phase II trial in progress Meeting Abstract
| Authors: | Paik, P.; Sakai, H.; Bruns, R.; Scheele, J.; Straub, J.; Felip, E. |
| Abstract Title: | Tepotinib in non-small cell lung cancer (NSCLC) with MET-exon 14 skipping mutations (METex14+) and MET amplification (METamp): A phase II trial in progress |
| Meeting Title: | ESMO Asia Congress 2018 |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2018 Nov 23-25 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-11-01 |
| Start Page: | mdy425.056 |
| Language: | English |
| ACCESSION: | WOS:000458082200057 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy425.056 |
| Notes: | Meeting Abstract: 546TiP -- Source: Wos |
